Tag: Eli Lilly

After weathering months of downward pressure, Indianapolis-based pharmaceutical giant Eli Lilly is demonstrating renewed strength. A series of significant developments ...

Eli Lilly confronts significant challenges this week as a US appellate court upheld a substantial $184 million penalty against the ...

Eli Lilly and Company shares are currently exhibiting a classic technical consolidation pattern, caught between well-defined support and resistance levels. ...

Friday proved to be a turbulent day for pharmaceutical giant Eli Lilly, with three significant developments creating a complex picture ...

Eli Lilly has generated significant attention in oncology circles following the FDA's decision to grant its lung cancer treatment Olomorasib ...

While Eli Lilly continues to dominate headlines with its blockbuster GLP-1 portfolio, a significant development is emerging from its oncology ...

Eli Lilly has gained significant competitive advantage in the development of innovative cancer therapies following a crucial regulatory decision by ...

Eli Lilly has secured a significant regulatory milestone from the U.S. Food and Drug Administration. The agency granted Breakthrough Therapy ...

Pharmaceutical titan Eli Lilly & Co. finds itself at the center of a Wall Street debate, presenting investors with a ...

Pharmaceutical giant Eli Lilly, already reaping billions from its revolutionary weight-loss and diabetes treatments, may be on the verge of ...